ResMed | RMD - EPS Earnings Per Share


ResMed reported $2.86 in EPS Earnings Per Share for its fiscal quarter ending in March of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q3 Mar/2026 2.86 2.82 2.37 Apr/30
FY2026Q2 Dec/2025 2.81 2.7 2.43 Jan/29
FY2026Q1 Sep/2025 2.55 2.52 2.20 Oct/30
FY2025Q4 Jun/2025 2.55 2.48 2.08 Jul/31
FY2025Q3 Mar/2025 2.37 2.41 2.13 Apr/23




Eps Change Date
Ansell USD 0.66 0.5 Dec/2025
Artivion USD -0.02 0.2 Dec/2025
AtriCure USD 0 0.06 Mar/2026
Baxter International USD 0.36 0.08 Mar/2026
Cochlear AUD 3.13 0.25 Dec/2025
Cooper Companies USD 1.04 0.38 Mar/2026
CSL USD 5.07 3 Dec/2025
Dexcom USD 0.56 0.12 Mar/2026
Edwards Lifesciences USD 0.78 0.2 Mar/2026
Fisher Paykel Healthcare NZD 0.38 0.01 Dec/2025
Globus Medical USD 1.12 0.16 Mar/2026
Haemonetics USD 1.29 0.02 Mar/2026
Idexx Laboratories USD 3.47 0.55 Mar/2026
Inogen USD -0.25 0.01 Sep/2024
Insulet USD 1.42 0.02 Mar/2026
Integra LifeSciences USD 0.54 0.29 Mar/2026
Intuitive Surgical USD 2.5 0.03 Mar/2026
Medtronic USD 1.55 0.19 Mar/2026
Philips EUR 0.23 0.37 Mar/2026
Ramsay Health Care AUD 0.66 0.01 Dec/2025
ResMed USD 2.86 0.05 Mar/2026
Sigma Healthcare AUD -0.01 0.01 Dec/2024
Sonic Healthcare AUD 0.53 0.04 Dec/2025
Steris USD 2.83 0.3 Mar/2026
Teleflex USD 1.39 0.54 Mar/2026
Thermo Fisher Scientific USD 5.44 1.13 Mar/2026